Recently, a clinical study from our group demonstrated that the plasma levels of IL-37 and the IL-37 expression in peripheral blood mononuclear cells were significantly increased in patients with acute coronary syndrome, which is the critical phase of coronary artery disease, compared to the control group16. The gene discussed is IL37; the disease is acute coronary syndrome.